Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells

Eleftherios Sachlos1, Ruth M Risueño, Sarah Laronde

  • 1McMaster Stem Cell and Cancer Research Institute, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.

Cell
|May 29, 2012
PubMed

Insights

Thioridazine, an antipsychotic, selectively targets cancer stem cells (CSCs) by antagonizing dopamine receptors. This discovery supports using differentiation as a therapeutic strategy and highlights dopamine receptors as potential cancer biomarkers.

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Pharmacology

Background:

  • Selective targeting of cancer stem cells (CSCs) is crucial for novel therapeutics.
  • Existing assays for human CSCs and normal stem cells are limited for biological screening.

Purpose of the Study:

  • To identify small molecules that selectively target and induce differentiation in neoplastic cells.
  • To explore the potential of targeting dopamine receptors on CSCs.

Main Methods:

  • Utilized a discovery platform comparing neoplastic and normal human pluripotent stem cells (hPSCs).
  • Screened libraries of known compounds to identify molecules inducing differentiation.
  • Investigated the effect of thioridazine on CSCs and normal stem cells in vitro and in vivo.

Main Results:

  • Thioridazine selectively targets neoplastic cells and impairs human somatic CSCs.
  • Normal blood stem cells were unaffected by thioridazine.
  • Dopamine receptors, expressed on CSCs and breast cancer cells, are antagonized by thioridazine.

Conclusions:

  • Neoplastic hPSCs are valuable for identifying CSC-targeting drugs.
  • Differentiation is a viable therapeutic strategy for overcoming neoplastic self-renewal.
  • Dopamine receptors may serve as biomarkers for various malignancies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...